SS&C Technologies Holdings Inc. Common Stock vs UnitedHealth Group Inc — how do they compare? SS&C Technologies Holdings Inc. Common Stock trades at $82.5 (market cap $19.25B), while UnitedHealth Group Inc trades at $399.01 (market cap $355.11B). The key difference: UnitedHealth Group Inc is far larger — about 18.4× SS&C Technologies Holdings Inc. Common Stock's market cap, and UnitedHealth Group Inc pays the higher dividend (2.35%). Which is the better fit depends on your goals — on Pluang, investors hold SS&C Technologies Holdings Inc. Common Stock for 0 Days and UnitedHealth Group Inc for 98 Days on average.
| SSNC | UNH | |
|---|---|---|
Market Cap | $19.25B | $355.11B |
Volume | 1,341,767 | 7,759,080 |
Sector | Technology | Health |
52-Week High | $89.62 | $436.35 |
52-Week Low | $62.05 | $259.02 |
Typical Hold Time | 0 Days | 98 Days |
Enterprise Value | $26.59B | $396.97B |
Dividend Yield | 1.46% | 2.35% |
Signals from Pluang's Aura AI — not financial advice
SSNC trades at $81.52, up 0.65% on the day, with a neutral technical signal. The company has consistently beaten earnings estimates in recent quarters (Q4 2025, Q1 2026, Q2 2026) and shows solid fundamentals, including a 13.16% net income margin and 12.73% ROE. Recent news highlights new client wins and AI-driven product enhancements, reinforcing its market position.
The outlook is positive, supported by strong analyst consensus (70.83% Buy rating) and a $91.50 price target, implying ~12% upside. Key risks include execution of growth initiatives and competitive pressures in the financial technology sector. The stock presents a compelling opportunity for investors seeking a fundamentally sound company with recurring revenue streams.
UnitedHealth Group (UNH) trades at $377.76, down 0.2% on the day, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $6.38 surpassing the $4.91 expectation. Revenue reached $447.57 billion in 2025, though net income margin declined to 2.69%. Recent news highlights dividend payments and strategic moves like the TPG deal for WellMed clinics.
UNH presents a favorable outlook with a consensus price target of $470.11, implying significant upside. Strengths include robust cash flow, a dominant market position, and AI investments in Optum. Risks involve regulatory pressures, rising medical costs, and debt levels. The stock remains a core holding for growth-oriented investors seeking healthcare exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SS&C Technologies Holdings, Inc. provides software and outsourced services for financial services and healthcare organizations, covering fund accounting, portfolio management, trading support, and regulatory reporting, and operates as a hedge fund and private equity administrator and mutual fund transfer agent.
Read more on SSNC →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →